LUIS GONZAGA
PAZ-ARES RODRÍGUEZ

Profesor titular de universidad

Foto de LUIS GONZAGA

Foto de Centre Léon Bérard

Centre Léon Bérard

Lyon, Francia

Publicaciones en colaboración con investigadores/as de Centre Léon Bérard (6)

2024

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study
Journal of Clinical Oncology

2022

Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
Nature Medicine, Vol. 28, Núm. 8, pp. 1640-1645
Trastuzumab deruxtecan in HER2-mutant non–small-cell lung cancer
New England Journal of Medicine, Vol. 386, Núm. 3, pp. 241-251

2019

Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial
The Lancet Oncology, Vol. 20, Núm. 8, pp. 1109-1123

2017

Nivolumab versus docetaxel in previously treated patients with advanced non-small-cell lung cancer: Two-year outcomes from two randomized, open-label, phase III Trials (CheckMate 017 and CheckMate 057)
Journal of Clinical Oncology, Vol. 35, Núm. 35, pp. 3924-3933

2004

Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors
Investigational New Drugs, Vol. 22, Núm. 3, pp. 329-333